Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.
about
MICAL-family proteins: Complex regulators of the actin cytoskeletonThe interaction of JRAB/MICAL-L2 with Rab8 and Rab13 coordinates the assembly of tight junctions and adherens junctionsElevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.Deregulation of Rab and Rab effector genes in bladder cancer.Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.Important relationships between Rab and MICAL proteins in endocytic trafficking.Differential regulation of actin microfilaments by human MICAL proteins.MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.Inhibition of Hec1 expression enhances the sensitivity of human ovarian cancer cells to paclitaxel.Extracellular inhibitors, repellents, and semaphorin/plexin/MICAL-mediated actin filament disassembly.MICALs in control of the cytoskeleton, exocytosis, and cell death.MICAL, the flavoenzyme participating in cytoskeleton dynamicsMolecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy.Actin filaments-A target for redox regulationRegulated methionine oxidation by monooxygenases.Redox regulation of the actin cytoskeleton and its role in the vascular system.Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer.Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering.Direct and indirect consequences on gene expression of a thyroid hormone receptor alpha 1 mutation restricted to Sertoli cells.Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR.Characterizing F-actin Disassembly Induced by the Semaphorin-Signaling Component MICAL.The MICALs are a Family of F-actin Dismantling Oxidoreductases Conserved from Drosophila to Humans.Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT.MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation.Amplification of F-Actin Disassembly and Cellular Repulsion by Growth Factor Signaling.Expressional analysis of disease-relevant signalling-pathways in primary tumours and metastasis of head and neck cancers.
P2860
Q26851932-F55BFE18-33C3-42E4-9EDD-161E1B6C81ADQ28587668-94C12F63-13DE-4F70-8BF0-2B4119F0AD69Q33269602-AD95EC85-F075-4C95-B047-03D5CA7AA167Q34314461-25BEAD58-273E-44DC-940C-DB13C8CA7790Q34621899-819DF157-7E4D-4F44-97AC-65C619839FFDQ34878926-5BD65924-A4BF-4520-A767-4A62B57412E8Q36010015-6B2910F9-6B27-4598-A6EF-7D494A55610AQ36738978-FE998C05-14D8-47C2-BB2C-FA9365AF05F1Q37728889-0287AEE0-456D-4A9D-8E5E-87AA8F6E4C37Q37908006-A5C4F0B0-5DFC-44D0-B533-2C742E85ADDAQ37913128-D8A611B7-5256-44E2-AB6D-6A5028E35038Q38093723-05DD14AD-07BC-4244-8659-11AD346C6C64Q38500301-455488EA-0AE8-47DB-8F05-D0A5532BBBEBQ38866879-A9C48275-0E99-40D0-A0A6-619D460D76B7Q39147645-FB04E5F7-EC5C-41E0-A714-ABE194FAB439Q39174495-2B672595-5ECE-4812-BF04-65231AD0A6CCQ39870904-6CA44843-4B68-45E2-B519-90D57786B6DCQ40077004-CDA1FD87-7F5E-45C4-852B-272489E1517BQ42775926-05ED2267-09ED-4880-9AFC-FF381B4C35DDQ44322819-2B7C246F-9EE3-4E5F-93FF-F97E8B202B98Q47118374-570B6CF8-F0F1-40C8-AC56-FF93A052E116Q49988888-094E1C98-D5B1-4A31-AFEC-A163C91FEE21Q50311627-93DB91A2-8F49-40C0-802F-AF0E3625644BQ50884256-0051F13E-F4B1-4B7E-A75B-833299889FAFQ50901053-8D4DFE5D-60FC-48CB-B96F-F1EE6F2A8019Q54979438-BECCFDB2-076F-4FC0-AA4E-480804C1D7BC
P2860
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of novel molecules, ...... d prostate cancer progression.
@ast
Expression of novel molecules, ...... d prostate cancer progression.
@en
type
label
Expression of novel molecules, ...... d prostate cancer progression.
@ast
Expression of novel molecules, ...... d prostate cancer progression.
@en
prefLabel
Expression of novel molecules, ...... d prostate cancer progression.
@ast
Expression of novel molecules, ...... d prostate cancer progression.
@en
P2093
P1476
Expression of novel molecules, ...... d prostate cancer progression.
@en
P2093
Hidewaki Nakagawa
Hiroki Yoshioka
Kenji Tamura
Mutsuo Furihata
Shingo Ashida
Taro Shuin
Tomoaki Fujioka
Toyomasa Katagiri
Tsuneharu Miki
Yoshio Anazawa
P304
P356
10.1158/1078-0432.CCR-05-1995
P407
P577
2006-05-01T00:00:00Z